
TSC Matters is a bimonthly e-newsletter featuring news from the TS Alliance, TSC research updates, upcoming TS Alliance events and more! Subscribe to stay up-to-date on everything happening at the TS Alliance.
Ongoing Early Intervention and Autism trials
See below for ongoing trials.Read More
Ongoing Biosample Studies
See below for ongoing studies.Read More
Alzheimer’s in TSC study
Tuberous Sclerosis Complex (TSC) is a genetic condition due to mutations in TSC1 or TSC2 commonly diagnosed in the first few years of life. Advances in TSC research has allowed TSC patients to live well beyond the age of 50. Subsequently, many TSC patients note brain function changes such as memory difficulties or problems learning new computer programs beginning in their mid-to-late 40’s. A research group at Duke University began characterizing these brain function changes in 2018. They believe that these changes may represent the early stages of a neurodegenerative condition.Read More
Have You or Your Loved One with TSC Been Diagnosed with COVID-19?
The TSC Alliance seeks to contact individuals with TSC who had COVID-19 infection to collect information in the TSC Natural History Database. TSC researchers will be using this information to help determine how medications such as everolimus (Afinitor®, Zortress®) or sirolimus (Rapamune®) and TSC conditions affect the risk of getting COVID-19 and its severity.Read More
Listen to the latest episode of TSC Now
Check out the newest episode of TSC Now, where host Dan Klein speaks with Justine Ravindranath, Commercial Operations Manager at Nobelpharma America, about the findings of an adult panel hosted by Nobelpharma America on Rare Disease Day. Dan also connects with Iris Mustich, an adult with TSC and TSC Alliance volunteer who was awarded the Keith Hall Distinguished Leadership Award during the Volunteer Leadership Celebration earlier this year. Listen now and subscribe wherever you listen to podcasts! ListenRead More
TSC-STEPS trial
TSC-STEPS is a study to learn more about a drug known as Sirolimus and determine if it can prevent seizures and epilepsy in children diagnosed with TSC. The study is currently enrolling infants diagnosed with TSC who are at risk of developing epilepsy. Learn more Listen to a recent episode of TSC Now featuring Darcy Krueger, MD, PhD, Principal Investigator for the TSC-STEPS trial.Read More
Register for a webinar about the RAINBOW study
Join us for a webinar discussing behaviors in TSC and the Remote Assessment and Intervention for Behavior Problems in Kids With TSC (RAINBOW).Read More
Tuberous Sclerosis Complex Travel and Lodging Patient Assistance Program
Bcureful’s Tuberous Sclerosis Complex Travel and Lodging Patient Assistance Program provides patients diagnosed with tuberous sclerosis complex (or under consideration for diagnosis) with financial assistance for travel and lodging related to participation in a clinical trial and or furtherance of treatment. Learn moreRead More
Anya’s Accelerator TAND Biomarker Workshop
With support from the The Ramesh and Kalpana Bhatia Family Foundation, the TSC Alliance hosted the first Anya’s Accelerator TAND Biomarker Workshop April 26-27, 2023 in Silver Spring, MD.Read More
11th Annual TSC Global Awareness Day Scheduled for May 15
On May 15, the TSC Alliance® will join tuberous sclerosis complex (TSC) organizations around the world to observe the 11th Annual TSC Global Awareness Day.Read More